Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Allurion Technologies, Inc. Common Stock (NY:ALUR)

2.690 -0.010 (-0.37%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allurion Technologies, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Allurion (ALUR) Stock Up 65% Today?
With Allurion launching its weight-loss management suite, ALUR stock skyrocketed amid popularity for the underlying treatment approach. 
Via InvestorPlace
Why Allurion Technologies Stock Is Racing Higher
Allurion Technologies' Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy, bariatric surgery, and weight... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 39,259.15 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%... 
Via Benzinga
Allurion Expands Virtual Care Suite to the United States
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023
ALUR stock results show that Allurion Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
From Allurion Technologies, Inc.
Via Business Wire
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From Allurion Technologies, Inc.
Via Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
From Allurion Technologies, Inc.
Via Business Wire
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
From Allurion Technologies, Inc.
Via Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
From Allurion Technologies, Inc.
Via Business Wire
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.